{"id":66231,"date":"2019-12-30T23:55:42","date_gmt":"2019-12-31T04:55:42","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/la-fda-concede-la-designacion-de-gran-avance\/"},"modified":"2019-12-30T23:55:42","modified_gmt":"2019-12-31T04:55:42","slug":"la-fda-concede-la-designacion-de-gran-avance","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/es\/la-fda-concede-la-designacion-de-gran-avance\/","title":{"rendered":"La FDA concede la designaci\u00f3n de gran avance"},"content":{"rendered":"<p>La Administraci\u00f3n de Alimentos y Medicamentos de EE.UU. ha concedido una Designaci\u00f3n de Terapia Innovadora al cobimetinib para el tratamiento de pacientes con neoplasias histioc\u00edticas (Erdheim-Chester Enfermedad de Rosai-Dorfman, Histiocitosis de Langerhans), que no portan la mutaci\u00f3n <em>BRAF<\/em> V600. Esto no s\u00f3lo supone un gran avance para los pacientes con ECD <em>BRAF negativo<\/em>, sino para todas las histiocitosis. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Administraci\u00f3n de Alimentos y Medicamentos de EE.UU. ha concedido una Designaci\u00f3n de Terapia Innovadora al cobimetinib para el tratamiento de pacientes con neoplasias histioc\u00edticas (Erdheim-Chester Enfermedad de Rosai-Dorfman, Histiocitosis [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":91091,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_wds_title":"","_wds_metadesc":"","_wds_focus-keywords":"","_wds_meta-robots-adv":"","_wds_meta-robots-noindex":false,"_wds_meta-robots-nofollow":false,"_wds_meta-robots-index":false,"_wds_meta-robots-follow":false,"_wds_autolinks-exclude":false,"_wds_canonical":"","_wds_redirect":"","_wds_opengraph":[],"_wds_twitter":[],"cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2078],"tags":[2122],"class_list":["post-66231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicados-de-prensa","tag-2019-es"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/posts\/66231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/comments?post=66231"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/posts\/66231\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/media\/91091"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/media?parent=66231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/categories?post=66231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/tags?post=66231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}